Skip to main content
Equibles

OCSAW · Oculis Holding AG

Track OCSAW — free

Use OCSAW with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research OCSAW.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.64 +0.28 (+11.86%) At close · Oct 21
Rebalance outlook locked
Market Cap
$484.70M
Shares
61.59M
Volume · Oct 21 10.87K Avg daily vol (3M) 5365

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$2.64 Open$2.97 Day$2.64–2.97 Available close range$2.23–5.13 Avg vol 30d6K Last earningsNov 5, 2026 DataJul 2026–Oct 2026

The closing range uses available history since Jul 23, 2026; less than a full year is stored.

Up next

Next earnings call
Nov 5, 2026 Scheduled · in 2 wks
Q1 2026 earnings call transcript
call held May 29, 2026

Quarterly results

Revenue Net income Net loss
· 250,000 CHF −12.88M CHF '23 Q2 ▼2% 245,000 CHF −20.84M CHF '24 Q2 ▲6.5% 261,000 CHF −25.38M CHF '25 Q2 LATEST ▲18.8% 310,000 CHF −9.97M CHF '26 Q2

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Distributing
2 of 65 funds reported for Sep 30 · net -76.3K sh shares
Insider flow Flat
No net insider activity over 90 days
Short interest Flat
No short-interest data
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
65 holders — near 3-yr high, broad support
Price context
position in its available closing range
Range low $2 Now $3 · 14% Range high $5

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
OCSAW
Oculis Holding AG
this stock
$484.70M — — — —
VRTX
Vertex Pharmaceuticals Inc
 $131.39B +15.7% +46.2% 30.2 1.8%
MRNA
Moderna, Inc.
 $98.14B +733.5% +4.3% — 7.7%
REGN
Regeneron Pharmaceuticals, Inc.
 $82.95B +4.4% +20.8% 20.0 2.1%
CSLLY
Csl Ltd
 $66.22B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
65
% held
38.3%
Reported
2 of 65
Top holder
EQT Fund Management S.a r…
Held Float
View
Short & Settlement
Fails to Deliver
FTD shares
23.8K
Value
$221.1K
As of
Sep 28, 2026
View
Filings
SEC Filings
Latest
6-K
Filed
Sep 30, 2026
This year
16
View
Proposed Sales
Value
$660.0K
Shares
25.0K
Filed
Mar 9, 2026
View
Earnings & Events
Webcasts Upcoming
Next webcast
Nov 5, 2026
Last webcast
Sep 16, 2026
View
Investor Relations
Upcoming events
4
View

Performance

5D 20D 120D MTD YTD
OCSAW +0.8% -42.9% — -9.0% —
SPY +0.5% +0.7% +7.6% +1.4% +13.4%
vs SPY +0.3% -43.6% — -10.3% —
Key facts CIK 1953530 CUSIP H5870P102 Visit website Investor relations